Blepharitis Pipeline Review, H1 2020 –

DUBLIN--(BUSINESS WIRE)--The "Blepharitis Pipeline Review, H1 2020" drug pipelines has been added to's offering. Blepharitis Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Blepharitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its c

Full Story →